Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-47.97%
operating margin TTM
-36.39%
revenue TTM
1.18 Million
revenue per share TTM
0.11$
valuation ratios | |
|---|---|
| pe ratio | -4.04 |
| peg ratio | -0.02 |
| price to book ratio | 4.18 |
| price to sales ratio | 1.81 |
| enterprise value multiple | -7.59 |
| price fair value | 4.18 |
profitability ratios | |
|---|---|
| gross profit margin | 89.52% |
| operating profit margin | -36.39% |
| pretax profit margin | -47.97% |
| net profit margin | -47.97% |
| return on assets | -45.96% |
| return on equity | -1136.5% |
| return on capital employed | -59.93% |
liquidity ratios | |
|---|---|
| current ratio | 2.02 |
| quick ratio | 1.90 |
| cash ratio | 1.27 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 185.08 |
| operating cycle | 261.82 |
| days of payables outstanding | 205.61 |
| cash conversion cycle | 56.21 |
| receivables turnover | 4.76 |
| payables turnover | 1.78 |
| inventory turnover | 1.97 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.04 |
| debt equity ratio | 0.09 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.08 |
| interest coverage | -2.37 |
| cash flow to debt ratio | -9.79 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.32 |
| cash per share | 1.93 |
| operating cash flow per share | -1.32 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -9.79 |
| short term coverage ratios | -18.97 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) reported earnings?
Verrica Pharmaceuticals Inc. (VRCA) published its most recent earnings results on 12-05-2026.
What is Verrica Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Verrica Pharmaceuticals Inc. (NASDAQ:VRCA)'s trailing twelve months ROE is -1136.5%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Verrica Pharmaceuticals Inc. (VRCA) currently has a ROA of -45.96%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VRCA's net profit margin stand at?
VRCA reported a profit margin of -47.97% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VRCA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.02 in the most recent quarter. The quick ratio stood at 1.90, with a Debt/Eq ratio of 0.09.